The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases

BMC Musculoskeletal Disorders

Volumn 15, Issue 1, 2014, Pages

  Sun, Shu ^a   Bay Jensen, Anne Christine ^a   Karsdal, Morten A ^a   Siebuhr, Anne Sofie ^a   Zheng, Qinlong ^b   Maksymowych, Walter P ^c,d   Christiansen, Thorbjørn G ^e   Henriksen, Kim ^a  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b Nordic Bioscience Biomarkers and Research   (China)

^c UNIVERSITY OF ALBERTA   (Canada)

^d Alberta Innovates Health Solutions   (Canada)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Active form; Ankylosing spondylitis; MMP 3; Rheumatoid arthritis; Serum

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; MONOCLONAL ANTIBODY; ONCOSTATIN M; STROMELYSIN; TUMOR NECROSIS FACTOR INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANKYLOSING SPONDYLITIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE TURNOVER; CARTILAGE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; EX VIVO STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVITIS; SYNOVIUM;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARTILAGE; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 3; MICE; MOLECULAR SEQUENCE DATA; ONCOSTATIN M; ORGAN CULTURE TECHNIQUES; OSTEOARTHRITIS, KNEE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPECIFIC PATHOGEN-FREE ORGANISMS; SPONDYLITIS, ANKYLOSING; SYNOVIAL MEMBRANE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899072113     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-15-93     Document Type: Article

References (32)

1. Ankylosing spondylitis. Braun J, Sieper J, Lancet 2007 369 1379 1390 10.1016/S0140-6736(07)60635-7 17448825
2. Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study. Bay-Jensen AC, Leeming DJ, Kleyer A, Veidal SS, Schett G, Karsdal MA, Rheumatol Int 2012 32 3565 3572 10.1007/s00296-011-2237-8 22086471
3. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Chen CH, Lin KC, Yu DT, Yang C, Huang F, Chen HA, Liang TH, Liao HT, Tsai CY, Wei JC, Chou CT, Rheumatology (Oxford) 2006 45 414 420 10.1093/rheumatology/kei208 16287916
4. Serum levels of matrix metalloproteinase 3 and macrophage colony-stimulating factor 1 correlate with disease activity in ankylosing spondylitis. Yang C, Gu J, Rihl M, Baeten D, Huang F, Zhao M, Zhang H, Maksymowych WP, De KF, Veys EM, Yu DT, Arthritis Rheum 2004 51 691 699 10.1002/art.20696 15478146
5. Synovial fibroblasts: key players in rheumatoid arthritis. Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T, Rheumatology (Oxford) 2006 45 669 675 10.1093/rheumatology/kel065 16567358
6. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Pap T, Muller-Ladner U, Gay RE, Gay S, Arthritis Res 2000 2 361 367 10.1186/ar113 11094449
7. Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. Wu JJ, Lark MW, Chun LE, Eyre DR, J Biol Chem 1991 266 5625 5628 2005102
8. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage. Flannery CR, Lark MW, Sandy JD, J Biol Chem 1992 267 1008 1014 1730630
9. Direct activation of human neutrophil procollagenase by recombinant stromelysin. Knauper V, Wilhelm SM, Seperack PK, DeClerck YA, Langley KE, Osthues A, Tschesche H, Biochem J 1993 295 Pt 2 581 586 8240261
10. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP). Shapiro SD, Fliszar CJ, Broekelmann TJ, Mecham RP, Senior RM, Welgus HG, J Biol Chem 1995 270 6351 6356 10.1074/jbc.270.11.6351 7890773
11. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Suzuki K, Enghild JJ, Morodomi T, Salvesen G, Nagase H, Biochemistry 1990 29 10261 10270 10.1021/bi00496a016 2176865
12. Biochemical characterization of human collagenase-3. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G, J Biol Chem 1996 271 1544 1550 10.1074/jbc.271.3.1544 8576151
13. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Visse R, Nagase H, Circ Res 2003 92 827 839 10.1161/01.RES.0000070112.80711.3D 12730128
14. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. Nagase H, Enghild JJ, Suzuki K, Salvesen G, Biochemistry 1990 29 5783 5789 10.1021/bi00476a020 2383557
15. The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophenylmercuric acetate. Okada Y, Harris ED Jr, Nagase H, Biochem J 1988 254 731 741 3058116
16. Serum levels of matrix metalloproteinase 3 (stromelysin 1) for monitoring synovitis in rheumatoid arthritis. Kobayashi A, Naito S, Enomoto H, Shiomoi T, Kimura T, Obata K, Inoue K, Okada Y, Arch Pathol Lab Med 2007 131 563 570 17425385
17. Serum levels of matrix metalloproteinase-3 in relation to the development of radiological damage in patients with early rheumatoid arthritis. Posthumus MD, Limburg PC, Westra J, Cats HA, Stewart RE, van Leeuwen MA, van Rijswijk MH, Rheumatology (Oxford) 1999 38 1081 1087 10.1093/rheumatology/38.11.1081 10556259
18. Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up. Houseman M, Potter C, Marshall N, Lakey R, Cawston T, Griffiths I, Young-Min S, Isaacs JD, Arthritis Res Ther 2012 14 30 10.1186/ar3734 22314025
19. Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Maksymowych WP, Landewe R, Conner-Spady B, Dougados M, Mielants H, van der TH, Poole AR, Wang N, van der HD, Arthritis Rheum 2007 56 1846 1853 10.1002/art.22589 17530713
20. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Lohmander LS, Hoerrner LA, Lark MW, Arthritis Rheum 1993 36 181 189 10.1002/art.1780360207 8431206
21. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Hulejova H, Baresova V, Klezl Z, Polanska M, Adam M, Senolt L, Cytokine 2007 38 151 156 10.1016/j.cyto.2007.06.001 17689092
22. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies. Obata K, Iwata K, Okada Y, Kohrin Y, Ohuchi E, Yoshida S, Shinmei M, Hayakawa T, Clin Chim Acta 1992 211 59 72 10.1016/0009-8981(92)90105-Y 1281763
23. A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen. Barascuk N, Veidal SS, Larsen L, Larsen DV, Larsen MR, Wang J, Zheng Q, Xing R, Cao Y, Rasmussen LM, Karsdal MA, Clin Biochem 2010 43 899 904 10.1016/j.clinbiochem.2010.03.012 20380828
24. A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Gefter ML, Margulies DH, Scharff MD, Somatic Cell Genet 1977 3 231 236 10.1007/BF01551818 605383
25. Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM-increased serum CIIM in subjects with severe radiographic osteoarthritis. Bay-Jensen AC, Liu Q, Byrjalsen I, Li Y, Wang J, Pedersen C, Leeming DJ, Dam EB, Zheng Q, Qvist P, Karsdal MA, Clin Biochem 2011 44 423 429 10.1016/j.clinbiochem.2011.01.001 21223960
26. Circulating citrullinated vimentin fragments reflect disease burden in ankylosing spondylitis and have prognostic capacity for radiographic progression. Bay-Jensen AC, Karsdal MA, Vassiliadis E, Wichuk S, Marcher-Mikkelsen K, Lories R, Christiansen C, Maksymowych WP, Arthritis Rheum 2013 65 972 980 10.1002/art.37843 23280360
27. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. Okada Y, Nagase H, Harris ED Jr, J Biol Chem 1986 261 14245 14255 3095317
28. Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Hui W, Rowan AD, Richards CD, Cawston TE, Arthritis Rheum 2003 48 3404 3418 10.1002/art.11333 14673992
29. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H, Ann Rheum Dis 1989 48 645 653 10.1136/ard.48.8.645 2675782
30. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. Baker AH, Edwards DR, Murphy G, J Cell Sci 2002 115 3719 3727 10.1242/jcs.00063 12235282
31. Preferential binding of collagenase to alpha 2-macroglobulin in the presence of the tissue inhibitor of metalloproteinases. Cawston TE, Mercer E, FEBS Lett 1986 209 9 12 10.1016/0014-5793(86)81074-2 2433154
32. Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation. Sottrup-Jensen L, J Biol Chem 1989 264 11539 11542 2473064